格隆溴铵-话题@MedSci

#格隆溴铵#

7篇内容 | 685人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1622064, encodeId=5754162206480, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=苑东生物「格隆溴铵注射液」即将第2家获批, objectType=article, longId=202182, objectId=099a2021824f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=099a2021824f, replyNumber=0, likeNumber=0, createdTime=2020-10-17, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=099a2021824f, moduleTitle=苑东生物「格隆溴铵注射液」即将第2家获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=099a2021824f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622063, encodeId=27651622063b5, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=重磅！【茚达特罗/格隆溴铵】进入国家医保目录，以期造福更多慢阻肺患者, objectType=article, longId=183758, objectId=9318183e584b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9318183e584b, replyNumber=0, likeNumber=29, createdTime=2019-11-30, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9318183e584b, moduleTitle=重磅！【茚达特罗/格隆溴铵】进入国家医保目录，以期造福更多慢阻肺患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9318183e584b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622062, encodeId=9d8e162206238, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=持续大力推进【格隆溴铵单方及茚达特罗/格隆溴铵复方】两药进入国家医保目录，旨在提高药物可及性，造福更多慢阻肺患者, objectType=article, longId=174697, objectId=616a1e46971c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616a1e46971c, replyNumber=0, likeNumber=30, createdTime=2019-07-04, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616a1e46971c, moduleTitle=持续大力推进【格隆溴铵单方及茚达特罗/格隆溴铵复方】两药进入国家医保目录，旨在提高药物可及性，造福更多慢阻肺患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616a1e46971c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622061, encodeId=9db916220612e, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=茚达特罗/格隆溴铵单方及复方，两药双双力争进入国家医保旨在提高药物可及性，造福更多慢阻肺患者, objectType=article, longId=166309, objectId=a5c6166309d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5c6166309d9, replyNumber=0, likeNumber=50, createdTime=2019-05-20, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5c6166309d9, moduleTitle=茚达特罗/格隆溴铵单方及复方，两药双双力争进入国家医保旨在提高药物可及性，造福更多慢阻肺患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5c6166309d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622060, encodeId=76031622060ee, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=Lancet：倍氯米松、福莫特罗以及格隆溴铵三联吸入治疗可有效缓解中重度COPD患者症状, objectType=article, longId=129448, objectId=5aa612944846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5aa612944846, replyNumber=0, likeNumber=37, createdTime=2018-02-11, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5aa612944846, moduleTitle=Lancet：倍氯米松、福莫特罗以及格隆溴铵三联吸入治疗可有效缓解中重度COPD患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5aa612944846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622059, encodeId=5c7116220596b, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=Respir Res：中度COPD患者症状未改善可否直接换药茚达特罗或格隆溴铵？, objectType=article, longId=110553, objectId=00dc1105537b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00dc1105537b, replyNumber=0, likeNumber=42, createdTime=2017-08-24, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00dc1105537b, moduleTitle=Respir Res：中度COPD患者症状未改善可否直接换药茚达特罗或格隆溴铵？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00dc1105537b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622058, encodeId=08f11622058aa, content=<a href='/topic/show?id=4bf26231e65' target=_blank style='color:#2F92EE;'>#格隆溴铵#</a>, objectTitle=NEJM：茚达特罗–格隆溴铵治疗COPD比沙美特罗–氟替卡松更有效, objectType=article, longId=68286, objectId=619f6828632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=619f6828632, replyNumber=0, likeNumber=41, createdTime=2016-05-17, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=619f6828632, moduleTitle=NEJM：茚达特罗–格隆溴铵治疗COPD比沙美特罗–氟替卡松更有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=619f6828632)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

格隆溴铵

2020-05-29

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

苑东生物「格隆溴铵注射液」即将第2家获批

2020-10-17

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

重磅！【茚达特罗/格隆溴铵】进入国家医保目录，以期造福更多慢阻肺患者

2019-11-30

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

持续大力推进【格隆溴铵单方及茚达特罗/格隆溴铵复方】两药进入国家医保目录，旨在提高药物可及性，造福更多慢阻肺患者

2019-07-04

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

茚达特罗/格隆溴铵单方及复方，两药双双力争进入国家医保旨在提高药物可及性，造福更多慢阻肺患者

2019-05-20

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

Lancet：倍氯米松、福莫特罗以及格隆溴铵三联吸入治疗可有效缓解中重度COPD患者症状

2018-02-11

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

Respir Res：中度COPD患者症状未改善可否直接换药茚达特罗或格隆溴铵？

2017-08-24

爆笑小医 (审核中...)

前往app查看评论内容

#格隆溴铵#

NEJM：茚达特罗–格隆溴铵治疗COPD比沙美特罗–氟替卡松更有效

2016-05-17

科室
- - 订阅+
  - 更多科室
工具
服务